A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)

Status:
Completed

Trial end date:
2011-02-14

Target enrollment:

Participant gender:

This study will assess the safety, tolerability and pharmacokinetics of sitagliptin in 10 to 17 year old diabetic patients.

Phase 1

Merck Sharp & Dohme Corp.

Sitagliptin Phosphate